The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles

We determined the direct effects of propofol on the contractility of human nonfailing atrial and failing atrial and ventricular muscles. Atrial and ventricular trabecular muscles were obtained from the failing human hearts of transplant patients or from nonfailing hearts of patients undergoing coron...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesia and analgesia 2001-09, Vol.93 (3), p.550-559
Hauptverfasser: Sprung, Juraj, Ogletree-Hughes, Monique L., McConnell, Bradley K., Zakhary, Daniel R., Smolsky, Shannon M., Moravec, Christine S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 559
container_issue 3
container_start_page 550
container_title Anesthesia and analgesia
container_volume 93
creator Sprung, Juraj
Ogletree-Hughes, Monique L.
McConnell, Bradley K.
Zakhary, Daniel R.
Smolsky, Shannon M.
Moravec, Christine S.
description We determined the direct effects of propofol on the contractility of human nonfailing atrial and failing atrial and ventricular muscles. Atrial and ventricular trabecular muscles were obtained from the failing human hearts of transplant patients or from nonfailing hearts of patients undergoing coronary artery bypass surgery. Isometric contraction variables were recorded before and after propofol was added to the bath in concentrations between 0.056 and 560 μM. The effects of propofol were compared with its commercial vehicle intralipid. To test β-adrenergic effects in the presence of propofol, 1 μM isoproterenol was added at the end of each experiment. To determine the cellular mechanisms responsible for the actions of propofol, we examined its effects on actomyosin ATPase activity and sarcoplasmic reticulum (SR) Ca2+ uptake in nonfailing atrial tissues. Propofol caused a concentration-dependent decrease in maximal developed tension in all muscles, which became significant (P < 0.05) at concentrations exceeding the clinical range (≥56 μM). Isoproterenol restored contractility to the level achieved before exposure to propofol (P > 0.05 compared with baseline). Failing ventricular muscle exposed to propofol exhibited somewhat diminished ability to recover contractility in response to isoproterenol (P < 0.05 versus failing muscle exposed to intralipid only). Propofol induced a concentration-dependent decrease in the uptake of Ca2+ into SR vesicles. At the same time, in the presence of 56 μM propofol, the Ca2+-activated actomyosin ATPase activity was shifted leftward, demonstrating an increase in myofilament sensitivity to Ca2+. We conclude that propofol exerts a direct negative inotropic effect in nonfailing and failing human myocardium, but only at concentrations larger than typical clinical concentrations. Negative inotropic effects are reversible with β-adrenergic stimulation. The negative inotropic effect of propofol is at least partially mediated by decreased Ca2+ uptake into the SR; however, the net effect of propofol on contractility is insignificant at clinical concentrations because of a simultaneous increase in the sensitivity of the myofilaments to activator Ca2+.
doi_str_mv 10.1097/00000539-200109000-00006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71128204</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71128204</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5016-247fddd43a5278dbf4d0867728dc3a55ede7de66184d3620265f3468e311415e3</originalsourceid><addsrcrecordid>eNp1kUtv3CAURlHVqJk8_kLFourODS-DvaxGSadSXot00w0icOm4ZcwUsKL8--KO-9iEDdzDuYA-EMKUfKCkVxdkHi3vG0ZIBbVoZiJfoRVtmWxU23ev0aoi3rC-74_RSc7fySx38g06ptUSnKoV-vqwBXzpPdiScfT4PsV99DHgOOJSt9ZxLMnYMoShPM_ClanL8Rs2o8O3cfRLuZl2ZsQbMKngmynbAPkMHXkTMpwv8yn6cnX5sN4013efPq8_Xje2JVQ2TCjvnBPctEx17tELVx-pFOucrawFB8qBlLQTjktGmGw9F7IDTqmgLfBT9P5w7j7FnxPkondDthCCGSFOWStKWceIqGJ3EG2KOSfwep-GnUnPmhI956r_5Kr_5vobydr6drljetyB-9e4BFmFd4tgsjXBJzPaIf_nEUl6WjVx0J5iKJDyjzA9QdJbMKFs9Uvfyn8B8bKNsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71128204</pqid></control><display><type>article</type><title>The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles</title><source>Journals@OVID</source><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>Journals@Ovid Complete</source><creator>Sprung, Juraj ; Ogletree-Hughes, Monique L. ; McConnell, Bradley K. ; Zakhary, Daniel R. ; Smolsky, Shannon M. ; Moravec, Christine S.</creator><creatorcontrib>Sprung, Juraj ; Ogletree-Hughes, Monique L. ; McConnell, Bradley K. ; Zakhary, Daniel R. ; Smolsky, Shannon M. ; Moravec, Christine S.</creatorcontrib><description>We determined the direct effects of propofol on the contractility of human nonfailing atrial and failing atrial and ventricular muscles. Atrial and ventricular trabecular muscles were obtained from the failing human hearts of transplant patients or from nonfailing hearts of patients undergoing coronary artery bypass surgery. Isometric contraction variables were recorded before and after propofol was added to the bath in concentrations between 0.056 and 560 μM. The effects of propofol were compared with its commercial vehicle intralipid. To test β-adrenergic effects in the presence of propofol, 1 μM isoproterenol was added at the end of each experiment. To determine the cellular mechanisms responsible for the actions of propofol, we examined its effects on actomyosin ATPase activity and sarcoplasmic reticulum (SR) Ca2+ uptake in nonfailing atrial tissues. Propofol caused a concentration-dependent decrease in maximal developed tension in all muscles, which became significant (P &lt; 0.05) at concentrations exceeding the clinical range (≥56 μM). Isoproterenol restored contractility to the level achieved before exposure to propofol (P &gt; 0.05 compared with baseline). Failing ventricular muscle exposed to propofol exhibited somewhat diminished ability to recover contractility in response to isoproterenol (P &lt; 0.05 versus failing muscle exposed to intralipid only). Propofol induced a concentration-dependent decrease in the uptake of Ca2+ into SR vesicles. At the same time, in the presence of 56 μM propofol, the Ca2+-activated actomyosin ATPase activity was shifted leftward, demonstrating an increase in myofilament sensitivity to Ca2+. We conclude that propofol exerts a direct negative inotropic effect in nonfailing and failing human myocardium, but only at concentrations larger than typical clinical concentrations. Negative inotropic effects are reversible with β-adrenergic stimulation. The negative inotropic effect of propofol is at least partially mediated by decreased Ca2+ uptake into the SR; however, the net effect of propofol on contractility is insignificant at clinical concentrations because of a simultaneous increase in the sensitivity of the myofilaments to activator Ca2+.</description><identifier>ISSN: 0003-2999</identifier><identifier>EISSN: 1526-7598</identifier><identifier>DOI: 10.1097/00000539-200109000-00006</identifier><identifier>PMID: 11524317</identifier><identifier>CODEN: AACRAT</identifier><language>eng</language><publisher>Hagerstown, MD: International Anesthesia Research Society</publisher><subject>Aged ; Anesthetics, Intravenous - pharmacology ; Anesthetics. Neuromuscular blocking agents ; Biological and medical sciences ; Calcium - metabolism ; Female ; Heart - drug effects ; Heart Failure - physiopathology ; Humans ; In Vitro Techniques ; Isometric Contraction - drug effects ; Male ; Medical sciences ; Middle Aged ; Myocardial Contraction - drug effects ; Myocardium - enzymology ; Myofibrils - drug effects ; Myofibrils - enzymology ; Myosins - metabolism ; Neuropharmacology ; Pharmacology. Drug treatments ; Propofol - pharmacology ; Sarcoplasmic Reticulum - drug effects ; Sarcoplasmic Reticulum - enzymology</subject><ispartof>Anesthesia and analgesia, 2001-09, Vol.93 (3), p.550-559</ispartof><rights>International Anesthesia Research Society</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5016-247fddd43a5278dbf4d0867728dc3a55ede7de66184d3620265f3468e311415e3</citedby><cites>FETCH-LOGICAL-c5016-247fddd43a5278dbf4d0867728dc3a55ede7de66184d3620265f3468e311415e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;NEWS=n&amp;CSC=Y&amp;PAGE=fulltext&amp;D=ovft&amp;AN=00000539-200109000-00006$$EHTML$$P50$$Gwolterskluwer$$H</linktohtml><link.rule.ids>314,776,780,4595,27901,27902,65206</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1106091$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11524317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sprung, Juraj</creatorcontrib><creatorcontrib>Ogletree-Hughes, Monique L.</creatorcontrib><creatorcontrib>McConnell, Bradley K.</creatorcontrib><creatorcontrib>Zakhary, Daniel R.</creatorcontrib><creatorcontrib>Smolsky, Shannon M.</creatorcontrib><creatorcontrib>Moravec, Christine S.</creatorcontrib><title>The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles</title><title>Anesthesia and analgesia</title><addtitle>Anesth Analg</addtitle><description>We determined the direct effects of propofol on the contractility of human nonfailing atrial and failing atrial and ventricular muscles. Atrial and ventricular trabecular muscles were obtained from the failing human hearts of transplant patients or from nonfailing hearts of patients undergoing coronary artery bypass surgery. Isometric contraction variables were recorded before and after propofol was added to the bath in concentrations between 0.056 and 560 μM. The effects of propofol were compared with its commercial vehicle intralipid. To test β-adrenergic effects in the presence of propofol, 1 μM isoproterenol was added at the end of each experiment. To determine the cellular mechanisms responsible for the actions of propofol, we examined its effects on actomyosin ATPase activity and sarcoplasmic reticulum (SR) Ca2+ uptake in nonfailing atrial tissues. Propofol caused a concentration-dependent decrease in maximal developed tension in all muscles, which became significant (P &lt; 0.05) at concentrations exceeding the clinical range (≥56 μM). Isoproterenol restored contractility to the level achieved before exposure to propofol (P &gt; 0.05 compared with baseline). Failing ventricular muscle exposed to propofol exhibited somewhat diminished ability to recover contractility in response to isoproterenol (P &lt; 0.05 versus failing muscle exposed to intralipid only). Propofol induced a concentration-dependent decrease in the uptake of Ca2+ into SR vesicles. At the same time, in the presence of 56 μM propofol, the Ca2+-activated actomyosin ATPase activity was shifted leftward, demonstrating an increase in myofilament sensitivity to Ca2+. We conclude that propofol exerts a direct negative inotropic effect in nonfailing and failing human myocardium, but only at concentrations larger than typical clinical concentrations. Negative inotropic effects are reversible with β-adrenergic stimulation. The negative inotropic effect of propofol is at least partially mediated by decreased Ca2+ uptake into the SR; however, the net effect of propofol on contractility is insignificant at clinical concentrations because of a simultaneous increase in the sensitivity of the myofilaments to activator Ca2+.</description><subject>Aged</subject><subject>Anesthetics, Intravenous - pharmacology</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Biological and medical sciences</subject><subject>Calcium - metabolism</subject><subject>Female</subject><subject>Heart - drug effects</subject><subject>Heart Failure - physiopathology</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Isometric Contraction - drug effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardium - enzymology</subject><subject>Myofibrils - drug effects</subject><subject>Myofibrils - enzymology</subject><subject>Myosins - metabolism</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Propofol - pharmacology</subject><subject>Sarcoplasmic Reticulum - drug effects</subject><subject>Sarcoplasmic Reticulum - enzymology</subject><issn>0003-2999</issn><issn>1526-7598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtv3CAURlHVqJk8_kLFourODS-DvaxGSadSXot00w0icOm4ZcwUsKL8--KO-9iEDdzDuYA-EMKUfKCkVxdkHi3vG0ZIBbVoZiJfoRVtmWxU23ev0aoi3rC-74_RSc7fySx38g06ptUSnKoV-vqwBXzpPdiScfT4PsV99DHgOOJSt9ZxLMnYMoShPM_ClanL8Rs2o8O3cfRLuZl2ZsQbMKngmynbAPkMHXkTMpwv8yn6cnX5sN4013efPq8_Xje2JVQ2TCjvnBPctEx17tELVx-pFOucrawFB8qBlLQTjktGmGw9F7IDTqmgLfBT9P5w7j7FnxPkondDthCCGSFOWStKWceIqGJ3EG2KOSfwep-GnUnPmhI956r_5Kr_5vobydr6drljetyB-9e4BFmFd4tgsjXBJzPaIf_nEUl6WjVx0J5iKJDyjzA9QdJbMKFs9Uvfyn8B8bKNsg</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>Sprung, Juraj</creator><creator>Ogletree-Hughes, Monique L.</creator><creator>McConnell, Bradley K.</creator><creator>Zakhary, Daniel R.</creator><creator>Smolsky, Shannon M.</creator><creator>Moravec, Christine S.</creator><general>International Anesthesia Research Society</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles</title><author>Sprung, Juraj ; Ogletree-Hughes, Monique L. ; McConnell, Bradley K. ; Zakhary, Daniel R. ; Smolsky, Shannon M. ; Moravec, Christine S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5016-247fddd43a5278dbf4d0867728dc3a55ede7de66184d3620265f3468e311415e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Aged</topic><topic>Anesthetics, Intravenous - pharmacology</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Biological and medical sciences</topic><topic>Calcium - metabolism</topic><topic>Female</topic><topic>Heart - drug effects</topic><topic>Heart Failure - physiopathology</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Isometric Contraction - drug effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardium - enzymology</topic><topic>Myofibrils - drug effects</topic><topic>Myofibrils - enzymology</topic><topic>Myosins - metabolism</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Propofol - pharmacology</topic><topic>Sarcoplasmic Reticulum - drug effects</topic><topic>Sarcoplasmic Reticulum - enzymology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sprung, Juraj</creatorcontrib><creatorcontrib>Ogletree-Hughes, Monique L.</creatorcontrib><creatorcontrib>McConnell, Bradley K.</creatorcontrib><creatorcontrib>Zakhary, Daniel R.</creatorcontrib><creatorcontrib>Smolsky, Shannon M.</creatorcontrib><creatorcontrib>Moravec, Christine S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesia and analgesia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sprung, Juraj</au><au>Ogletree-Hughes, Monique L.</au><au>McConnell, Bradley K.</au><au>Zakhary, Daniel R.</au><au>Smolsky, Shannon M.</au><au>Moravec, Christine S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles</atitle><jtitle>Anesthesia and analgesia</jtitle><addtitle>Anesth Analg</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>93</volume><issue>3</issue><spage>550</spage><epage>559</epage><pages>550-559</pages><issn>0003-2999</issn><eissn>1526-7598</eissn><coden>AACRAT</coden><abstract>We determined the direct effects of propofol on the contractility of human nonfailing atrial and failing atrial and ventricular muscles. Atrial and ventricular trabecular muscles were obtained from the failing human hearts of transplant patients or from nonfailing hearts of patients undergoing coronary artery bypass surgery. Isometric contraction variables were recorded before and after propofol was added to the bath in concentrations between 0.056 and 560 μM. The effects of propofol were compared with its commercial vehicle intralipid. To test β-adrenergic effects in the presence of propofol, 1 μM isoproterenol was added at the end of each experiment. To determine the cellular mechanisms responsible for the actions of propofol, we examined its effects on actomyosin ATPase activity and sarcoplasmic reticulum (SR) Ca2+ uptake in nonfailing atrial tissues. Propofol caused a concentration-dependent decrease in maximal developed tension in all muscles, which became significant (P &lt; 0.05) at concentrations exceeding the clinical range (≥56 μM). Isoproterenol restored contractility to the level achieved before exposure to propofol (P &gt; 0.05 compared with baseline). Failing ventricular muscle exposed to propofol exhibited somewhat diminished ability to recover contractility in response to isoproterenol (P &lt; 0.05 versus failing muscle exposed to intralipid only). Propofol induced a concentration-dependent decrease in the uptake of Ca2+ into SR vesicles. At the same time, in the presence of 56 μM propofol, the Ca2+-activated actomyosin ATPase activity was shifted leftward, demonstrating an increase in myofilament sensitivity to Ca2+. We conclude that propofol exerts a direct negative inotropic effect in nonfailing and failing human myocardium, but only at concentrations larger than typical clinical concentrations. Negative inotropic effects are reversible with β-adrenergic stimulation. The negative inotropic effect of propofol is at least partially mediated by decreased Ca2+ uptake into the SR; however, the net effect of propofol on contractility is insignificant at clinical concentrations because of a simultaneous increase in the sensitivity of the myofilaments to activator Ca2+.</abstract><cop>Hagerstown, MD</cop><pub>International Anesthesia Research Society</pub><pmid>11524317</pmid><doi>10.1097/00000539-200109000-00006</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-2999
ispartof Anesthesia and analgesia, 2001-09, Vol.93 (3), p.550-559
issn 0003-2999
1526-7598
language eng
recordid cdi_proquest_miscellaneous_71128204
source Journals@OVID; MEDLINE; EZB Electronic Journals Library; Journals@Ovid Complete
subjects Aged
Anesthetics, Intravenous - pharmacology
Anesthetics. Neuromuscular blocking agents
Biological and medical sciences
Calcium - metabolism
Female
Heart - drug effects
Heart Failure - physiopathology
Humans
In Vitro Techniques
Isometric Contraction - drug effects
Male
Medical sciences
Middle Aged
Myocardial Contraction - drug effects
Myocardium - enzymology
Myofibrils - drug effects
Myofibrils - enzymology
Myosins - metabolism
Neuropharmacology
Pharmacology. Drug treatments
Propofol - pharmacology
Sarcoplasmic Reticulum - drug effects
Sarcoplasmic Reticulum - enzymology
title The Effects of Propofol on the Contractility of Failing and Nonfailing Human Heart Muscles
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T12%3A37%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effects%20of%20Propofol%20on%20the%20Contractility%20of%20Failing%20and%20Nonfailing%20Human%20Heart%20Muscles&rft.jtitle=Anesthesia%20and%20analgesia&rft.au=Sprung,%20Juraj&rft.date=2001-09-01&rft.volume=93&rft.issue=3&rft.spage=550&rft.epage=559&rft.pages=550-559&rft.issn=0003-2999&rft.eissn=1526-7598&rft.coden=AACRAT&rft_id=info:doi/10.1097/00000539-200109000-00006&rft_dat=%3Cproquest_cross%3E71128204%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71128204&rft_id=info:pmid/11524317&rfr_iscdi=true